CD38-Targeted
89
Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care
J Nucl Med
.
2025 Mar 3;66(3):482.
doi: 10.2967/jnumed.124.269393.
Authors
Gary A Ulaner
1
2
,
Jason Lewis
3
,
Ola Landgren
4
Affiliations
1
Molecular Imaging and Therapy, Hoag Family Cancer Institute, Irvine, California; gary.ulaner@hoag.org.
2
Radiology and Translational Genomics, University of Southern California, Los Angeles, California.
3
Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
4
Division of Myeloma, University of Miami, Miami, Florida.
PMID:
39884767
DOI:
10.2967/jnumed.124.269393
No abstract available